Status:

COMPLETED

Colorectal Cancer Screening for Cancer Survivors

Lead Sponsor:

University Health Network, Toronto

Collaborating Sponsors:

Princess Margaret Hospital, Canada

Conditions:

Colorectal Cancer

Eligibility:

All Genders

35-49 years

Brief Summary

The risk of colorectal cancer (CRC) is significant among cancer survivors treated with abdominal radiation therapy (RT). Further, CRC is once of the few cancers for which there is effective screening....

Detailed Description

Cancer survivors meeting the COG criteria for CRC screening will undergo colonoscopy and removal of colorectal polyps. Documentation of polyp number, location and pathologic characteristics will be ma...

Eligibility Criteria

Inclusion

  • Asymptomatic survivors treated with ≥ 25Gy to the abdomen, pelvis or spine, or ≥ 12Gy total body radiation therapy, or ≥ 12Gy whole abdominal RT.
  • Patients who have passed ≥10 years following RT
  • Patients whose current age is 35-49.

Exclusion

  • Patients with signs/symptoms suggestive of CRC or other high-risk features such as:
  • Persistent constipation for \>2 weeks in the last month
  • One or more unexplained episodes of red blood in the stool in the last month
  • One or more unexplained episodes of black stool in the last month
  • Unexplained pelvic pain in the last month
  • Patients with a history of Crohn's disease or ulcerative colitis
  • Patients already taking part in a colorectal screening program defined as any colorectal screening (colonoscopy, sigmoidoscopy, fecal occult blood test) within last 5 years.
  • Patients with self-reported history of colorectal polyps.

Key Trial Info

Start Date :

May 1 2008

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

January 24 2018

Estimated Enrollment :

140 Patients enrolled

Trial Details

Trial ID

NCT00982059

Start Date

May 1 2008

End Date

January 24 2018

Last Update

January 31 2018

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Dana-Farber Cancer Institute

Boston, Massachusetts, United States, 02115

2

University Health Network

Toronto, Ontario, Canada, M5G 2M9

Colorectal Cancer Screening for Cancer Survivors | DecenTrialz